フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
MediPharm Labs Reports Fourth Quarter and Full Year 2021 Results PR Newswire TORONTO, March 31, 2022 TORONTO...
MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2021 Financial Results PR Newswire TORONTO...
MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF PR Newswire TORONTO, Feb...
TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ...
MediPharm Labs pharma-quality CBD dominant oil line has been awarded CBD Brand of the year by KIND...
Strong cash balance and continued reduction of convertible debt to less than $500K.Opportunities for...
BARRIE, Ontario, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ...
Patient based delivery of medical cannabis executed with approval from both Barbados and Canadian Health...
A leader in CBN products, MediPharm Labs, adds CBN:CBD products to its wellness portfolio for consumers and...
BARRIE, Ontario, Nov. 15, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ...
TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ...
C-Suite healthcare leader, Bryan Howcroft, to lead MediPharm’s next phase of international growth as CEO. Bryan...
New strategic partnership through the delivery of GMP extract to Germany for Vayamed, the medical cannabis...
McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has...
Received first instalment of a government grant for $330,000AUD as part of the Australian government’s...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約